Naturally Occurring Symptoms May Be Mistaken for Tamoxifen Side Effects
 December 9, 2016   Cancer Research UK
 
 Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug if they
 suffered nausea and vomiting, according to new data presented at the San Antonio Breast Cancer
 Symposium today.

 The researchers found that women who experienced these symptoms after starting tamoxifen as
 part of the Cancer Research UK funded International Breast Cancer Intervention Study (IBIS-1),
 were more likely to stop taking the medication.
 
 But this new analysis also reveals that women given a placebo who experienced the same
 symptoms were equally as likely to stop. This suggests that some symptoms due to other causes, 
 were being mistaken for side effects of tamoxifen.
 
 Previous results from the IBIS-1 trial showed that tamoxifen reduces the incidence of breast cancer
 among women at a high risk of the disease by over 30 per cent. These preventive effects last for
 more than 20 years.

 However, a third of women on the trial did not continue with treatment for the recommended five
 years.

 In this examination of the trial data, the researchers based at the University of Leeds and Queen
 Mary University of London, looked at symptoms that may have led to women not taking the full
 course of therapy.

 While some women who stopped the medication experienced menopausal side effects including hot
 flushes and gynecological changes, others may have stopped after mistakenly linking vomiting and
 nausea to the drug. This suggests that the understanding of what may be causing certain symptoms
 could be an important barrier to some women continuing with tamoxifen.
 
 The highest drop-out rates occurred within the first 12 months of the IBIS-1 trial, highlighting a period
 during which interventions to support women should be targeted.
 
 Dr Samuel Smith, a Cancer Research UK fellow and university academic fellow at the University of
 Leeds, said: "Our findings have implications for how doctors talk to patients about the benefits and
 side effects of preventive therapies such as tamoxifen.
 
 "It's important to manage expectations and provide accurate information on the likelihood of
 experiencing specific side effects and how these differ from symptoms that women may experience
 anyway.

 "The high drop-out rate observed in the early stages of the trial suggest that more support is needed 
 to help women understand and manage side-effects that may be linked to their treatment."
 
 Sarah Williams, Cancer Research UK's health information manager, said: "Breast cancer is the
 most common cancer in the UK but research is helping us find new ways of preventing the disease  
 in women at high risk.
 
 "While drugs such as tamoxifen and anastrozole can cut the risk of the disease, they do cause side
 effects. Research like this to understand more about the side effects women experience and the
 decisions this leads them to make, is vital to offering them appropriate support so they can make the
 best choice for them.
 
 "It's important for anyone experiencing symptoms that are unusual for them, that don't clear up, or
 that keep coming back to tell their doctor."
 
Almost 20 Percent of Breast Cancer Patients Fail to Complete Prescribed Endocrine Therapy

 SAVE THE DATE
March 5th - Breast Cancer Options BENEFIT concert at the Falcon
Doors, Bar & Restaurant Open at 5:30. Music at 7:00. No Tickets. No Cover.  
 Donations Encouraged! For Falcon Dining: Reserve your table: http://www.liveatthefalcon.com/reservations, or Call: 845 236 7970
 
 The band features: John Abercrombie/Guitar, Marc Copland/Piano, Drew
 Gress/Bass,and Mark Ferber/Drums
 
 John Abercrombie/Guitar-johnabercrombie.com  
 Over a career spanning more than 40 years and nearly 50 albums, John Abercrombie has
 established himself as one the masters of jazz guitar. Abercrombie is a restless experimenter,
 working firmly in the jazz tradition while pushing the boundaries of meter and harmony.
 
 Marc Copland/Piano-http://www.marccopland.com  
 Modern jazz pianist, composer, and recording artist, Marc Copland, whose n5ickname "the
 Piano Whisperer" was earned for his rich harmonic technique and crystalline sound. He became
 an integral part of Philly's jazz scene, lending his talents to a number of bandleaders, including
 Chico Hamilton, Cameron Brown, and Jeff Williams, and collaborated with guitarists John 
 Abercrombie and Ralph Towner. 
 
 Bassist/composer Drew Gress performs extensively with artists on the cutting edge of
 contemporary improvised music. Drew can also be heard within the ensembles of John  
 Abercrombie, Ravi Coltrane, and Fred Hersch. He has toured worldwide, and served as Artist-
 in-Residence at St. Petersburg Conservatory in Russia and at the Paris Conservatoire.
 
 Drummer Mark Ferber's work includes tours and recordings with Lee Konitz, Don Byron, Fred
 Hersch, among others. Mark has taught extensively in the US and Europe, and is a faculty
 member for the California Institute of the Arts, the Tavira Jazz Workshop in Portugal, the
 School of Improvisational Music (SIM), and is currently teaching privately out of the City College
 of New York.


The Falcon-1348 Route 9W, Marlboro NY 12542
(845) 236-7970